News & Press.

Aziyo Biologics to Participate in Upcoming Investor Conferences

Nov 21, 2022 | News & Press

SILVER SPRING, Md., Nov. 21, 2022 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a biologics company with a portfolio of regenerative products aimed at improving compatibility between medical devices and the patients they treat, today announced that management will be participating in the following investor conferences:

34th Annual Piper Sandler Healthcare Conference
Location: New York, NY
Format: Fireside chat and 1×1 meetings
Date: December 1, 2022
Time: 11:30 a.m. ET
Participants: C. Randall Mills, Ph.D., President and Chief Executive Officer, and Matthew Ferguson, Chief Financial Officer

Cantor Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
Location: Miami, FL
Format: Panel discussion entitled “R&R: Regenerative & Restoration Medicine” and 1×1 meetings
Date: December 8, 2022
Time: 2:45 p.m. ET
Participant: C. Randal Mills, Ph.D.

A webcast of the fireside chat at the Piper Sandler conference can be accessed by visiting A replay will be available on the Company’s website following the event. A recording of the panel discussion at the Cantor conference will be made available only to clients of Cantor Fitzgerald.

About Aziyo Biologics
Aziyo Biologics is a regenerative medicine company with a commercial portfolio of differentiated products focused on improving outcomes in patients undergoing a range of surgical procedures, primarily for implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit

Matt Ferguson
Aziyo Biologics, Inc.

Courtney Guyer
Aziyo Biologics, Inc.

Want to Stay up to Date on the Latest News?

Click below to join our mailing list.
External links are provided for informational purposes only.
Aziyo bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.